Table 2. Upregulated genes of selected enriched gene ontology categories following irradiation are shown based on sets of statistically significant changes (P < 0.05).
Gene Ontology Category | P-value | Fold change | Gene symbol | Gene description |
---|---|---|---|---|
GO:0010718:Positive regulation of epithelial to mesenchymal transition | 4.90E–03 | 2.32 | BAMBI | BMP and activin membrane bound inhibitor |
2 | GLIPR2 | GLI pathogenesis related 2 | ||
2.23 | AXIN2 | axin 2 | ||
4.78 | COL1A1 | collagen type I alpha 1 chain | ||
2.79 | TGFB3 | transforming growth factor beta 3 | ||
GO:0001525: Angiogenesis | 2.00E–02 | 2.46 | CXCL8 | C-X-C motif chemokine ligand 8 |
5.1 | EPHB3 | EPH receptor B3 | ||
2.2 | EPHB4 | EPH receptor B4 | ||
5.79 | ACKR3 | atypical chemokine receptor 3 | ||
2 | CSPG4 | chondroitin sulfate proteoglycan 4 | ||
2.48 | COL8A1 | collagen type VIII alpha 1 chain | ||
3 | NRXN3 | neurexin 3 | ||
3.16 | NDNF | neuron derived neurotrophic factor | ||
3.68 | NRP2 | neuropilin 2 | ||
2.611 | SERPINE1 | serpin family E member 1 | ||
3.2 | ZC3H12A | zinc finger CCCH-type containing 12A | ||
GO:0016049: Cell growth | 3.00E–02 | 14.44 | ROS1 | ROS proto-oncogene 1, receptor tyrosine kinase |
3.07 | EDN1 | endothelin 1 | ||
2.43 | IL7R | interleukin 7 receptor | ||
3.16 | NDNF | neuron derived neurotrophic factor | ||
2.79 | TGFB3 | transforming growth factor beta 3 | ||
GO:0008283: Cell proliferation | 2.30E–02 | 2.18 | E2F8 | E2F transcription factor 8 |
4.84 | ERG | ERG, ETS transcription factor | ||
14.44 | ROS1 | ROS proto-oncogene 1, receptor tyrosine kinase | ||
4.47 | ALK | anaplastic lymphoma receptor tyrosine kinase | ||
2.23 | AXIN2 | axin 2 | ||
3 | CDC25A | cell division cycle 25A | ||
2.02 | CSPG4 | chondroitin sulfate proteoglycan 4 | ||
4.19 | CYP1A1 | cytochrome P450 family 1 subfamily A member 1 | ||
3.23 | DLX5 | distal-less homeobox 5 | ||
2.14 | FSCN1 | fascin actin-bundling protein 1 | ||
2.76 | FGF5 | fibroblast growth factor 5 | ||
2.62 | GRPR | gastrin releasing peptide receptor | ||
5.56 | MYH10 | myosin heavy chain 10 | ||
2.47 | PDK1 | pyruvate dehydrogenase kinase 1 | ||
2.25 | UHRF1 | ubiquitin like with PHD and ring finger domains 1 | ||
GO:0004222: Metalloendopeptidase activity | 5.70E–04 | 3 | ADAM12 | ADAM metallopeptidase domain 12 |
2.79 | ADAM19 | ADAM metallopeptidase domain 19 | ||
2.59 | ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif 1 | ||
2.73 | ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif 14 | ||
2.25 | BMP1 | bone morphogenetic protein 1 | ||
3.15 | MMP12 | matrix metallopeptidase 12 | ||
5.55 | MMP3 | matrix metallopeptidase 3 | ||
5.69 | MMP7 | matrix metallopeptidase 7 | ||
2.35 | MME | membrane metalloendopeptidase | ||
2.4 | TSHZ2 | teashirt zinc finger homeobox 2 | ||
GO:0001666: Response to hypoxia | 2.90E–02 | 5.69 | ABAT | 4-aminobutyrate aminotransferase |
2.73 | BNIP3 | BCL2 interacting protein 3 | ||
5.6 | CA9 | carbonic anhydrase 9 | ||
4.17 | CYP1A1 | cytochrome P450 family 1 subfamily A member 1 | ||
3.84 | EGLN3 | egl-9 family hypoxia inducible factor 3 | ||
2.25 | LOXL2 | lysyl oxidase like 2 | ||
2.72 | MUC1 | mucin 1, cell surface associated | ||
10.81 | POSTN | periostin | ||
2.79 | TGFB3 | transforming growth factor beta 3 | ||
1.80 | HIF-1α | Hypoxia-inducible factor 1-alpha | ||
GO:0016477: Cell migration | 2.90E–04 | 2.32 | BAMBI | BMP and activin membrane bound inhibitor |
2.39 | EPHA3 | EPH receptor A3 | ||
5.1 | EPHB3 | EPH receptor B3 | ||
4.84 | ERG | ERG, ETS transcription factor | ||
2.95 | WWC1 | WW and C2 domain containing 1 | ||
2.06 | BDKRB1 | bradykinin receptor B1 | ||
2 | CSPG4 | chondroitin sulfate proteoglycan 4 | ||
2.41 | COL5A1 | collagen type V alpha 1 chain | ||
2.14 | FSCN1 | fascin actin-bundling protein 1 | ||
3.66 | LCP1 | lymphocyte cytosolic protein 1 | ||
3.3 | PODXL | podocalyxin like | ||
4.48 | PSG2 | pregnancy specific beta-1-glycoprotein 2 | ||
2.83 | SDC1 | syndecan 1 |
Experiments were performed in triplicates.